Design, synthesis and evaluation of 2,4-diarylpyrano[3,2-c]chromen-5(4H)-one as a new class of non-purine xanthine oxidase inhibitors

Harpreet S. Virdi, Sahil Sharma, Samir Mehndiratta, P. M.S. Bedi, Kunal Nepali

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Keeping in view the recent success of molecular hybridization technique in drug design, 2,4-diarylpyrano[3,2-c]chromen-5(4H)-ones as conjugates of coumarins and chalcones have been designed and synthesized in the present study. The catalytic efficiency of various Lewis acids for the synthesis of designed conjugates under neat conditions was investigated, and SiO2 (200-400 mesh)-ZnCl2 was optimized as the best catalyst among the tested ones. The conjugates were evaluated for in-vitro xanthine oxidase activity. The results of the in-vitro assay were quite promising as some conjugates were endowed with remarkable inhibitory potential against the enzyme. HV-8, 11 and 12 were found to be high-potent inhibitors with HV-11 (the most potent inhibitor) possessing an IC50 value of 2.21 μM. The most active conjugate HV-11 was evaluated for the type of inhibition and was found to be a mixed type inhibitor. The compliance of some selected conjugates to the Lipinski rule was also calculated.

Original languageEnglish
Pages (from-to)730-736
Number of pages7
JournalJournal of Enzyme Inhibition and Medicinal Chemistry
Volume30
Issue number5
DOIs
Publication statusPublished - Sep 3 2015
Externally publishedYes

Fingerprint

Xanthine Oxidase
Chalcones
Coumarins
Lewis Acids
Drug Design
Inhibitory Concentration 50
Compliance
Enzymes
In Vitro Techniques

Keywords

  • Conjugates
  • inhibition
  • lipinski rule
  • mixed
  • silica
  • xanthine oxidase

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

Design, synthesis and evaluation of 2,4-diarylpyrano[3,2-c]chromen-5(4H)-one as a new class of non-purine xanthine oxidase inhibitors. / Virdi, Harpreet S.; Sharma, Sahil; Mehndiratta, Samir; Bedi, P. M.S.; Nepali, Kunal.

In: Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 30, No. 5, 03.09.2015, p. 730-736.

Research output: Contribution to journalArticle

@article{3a3ec8e7747d452785d5a81aa835bd66,
title = "Design, synthesis and evaluation of 2,4-diarylpyrano[3,2-c]chromen-5(4H)-one as a new class of non-purine xanthine oxidase inhibitors",
abstract = "Keeping in view the recent success of molecular hybridization technique in drug design, 2,4-diarylpyrano[3,2-c]chromen-5(4H)-ones as conjugates of coumarins and chalcones have been designed and synthesized in the present study. The catalytic efficiency of various Lewis acids for the synthesis of designed conjugates under neat conditions was investigated, and SiO2 (200-400 mesh)-ZnCl2 was optimized as the best catalyst among the tested ones. The conjugates were evaluated for in-vitro xanthine oxidase activity. The results of the in-vitro assay were quite promising as some conjugates were endowed with remarkable inhibitory potential against the enzyme. HV-8, 11 and 12 were found to be high-potent inhibitors with HV-11 (the most potent inhibitor) possessing an IC50 value of 2.21 μM. The most active conjugate HV-11 was evaluated for the type of inhibition and was found to be a mixed type inhibitor. The compliance of some selected conjugates to the Lipinski rule was also calculated.",
keywords = "Conjugates, inhibition, lipinski rule, mixed, silica, xanthine oxidase",
author = "Virdi, {Harpreet S.} and Sahil Sharma and Samir Mehndiratta and Bedi, {P. M.S.} and Kunal Nepali",
year = "2015",
month = "9",
day = "3",
doi = "10.3109/14756366.2014.961446",
language = "English",
volume = "30",
pages = "730--736",
journal = "Journal of Enzyme Inhibition and Medicinal Chemistry",
issn = "1475-6366",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - Design, synthesis and evaluation of 2,4-diarylpyrano[3,2-c]chromen-5(4H)-one as a new class of non-purine xanthine oxidase inhibitors

AU - Virdi, Harpreet S.

AU - Sharma, Sahil

AU - Mehndiratta, Samir

AU - Bedi, P. M.S.

AU - Nepali, Kunal

PY - 2015/9/3

Y1 - 2015/9/3

N2 - Keeping in view the recent success of molecular hybridization technique in drug design, 2,4-diarylpyrano[3,2-c]chromen-5(4H)-ones as conjugates of coumarins and chalcones have been designed and synthesized in the present study. The catalytic efficiency of various Lewis acids for the synthesis of designed conjugates under neat conditions was investigated, and SiO2 (200-400 mesh)-ZnCl2 was optimized as the best catalyst among the tested ones. The conjugates were evaluated for in-vitro xanthine oxidase activity. The results of the in-vitro assay were quite promising as some conjugates were endowed with remarkable inhibitory potential against the enzyme. HV-8, 11 and 12 were found to be high-potent inhibitors with HV-11 (the most potent inhibitor) possessing an IC50 value of 2.21 μM. The most active conjugate HV-11 was evaluated for the type of inhibition and was found to be a mixed type inhibitor. The compliance of some selected conjugates to the Lipinski rule was also calculated.

AB - Keeping in view the recent success of molecular hybridization technique in drug design, 2,4-diarylpyrano[3,2-c]chromen-5(4H)-ones as conjugates of coumarins and chalcones have been designed and synthesized in the present study. The catalytic efficiency of various Lewis acids for the synthesis of designed conjugates under neat conditions was investigated, and SiO2 (200-400 mesh)-ZnCl2 was optimized as the best catalyst among the tested ones. The conjugates were evaluated for in-vitro xanthine oxidase activity. The results of the in-vitro assay were quite promising as some conjugates were endowed with remarkable inhibitory potential against the enzyme. HV-8, 11 and 12 were found to be high-potent inhibitors with HV-11 (the most potent inhibitor) possessing an IC50 value of 2.21 μM. The most active conjugate HV-11 was evaluated for the type of inhibition and was found to be a mixed type inhibitor. The compliance of some selected conjugates to the Lipinski rule was also calculated.

KW - Conjugates

KW - inhibition

KW - lipinski rule

KW - mixed

KW - silica

KW - xanthine oxidase

UR - http://www.scopus.com/inward/record.url?scp=84940777127&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940777127&partnerID=8YFLogxK

U2 - 10.3109/14756366.2014.961446

DO - 10.3109/14756366.2014.961446

M3 - Article

AN - SCOPUS:84940777127

VL - 30

SP - 730

EP - 736

JO - Journal of Enzyme Inhibition and Medicinal Chemistry

JF - Journal of Enzyme Inhibition and Medicinal Chemistry

SN - 1475-6366

IS - 5

ER -